Satsuma Pharmaceuticals is a biopharmaceutical company preparing to launch AtzumiTM (dihydroergotamine (DHE) nasal powder), a novel therapeutic product approved in the US for the acute treatment of migraine. AtzumiTM incorporates proprietary advanced powder and device technology (SMART – Simple MucoAdhesive Release Technology™) and is designed to be easy-to-use, easy-to-carry and for quick self-administration. The Director, Scientific Communications, will lead the development and execution of scientific communication strategies supporting Satsuma Pharmaceuticals' portfolio of innovative therapies for the acute treatment of migraine. This individual will be responsible for translating complex scientific and clinical data into clear, accurate, and compelling communications for healthcare professionals, scientific audiences, payers, and internal stakeholders. Working cross-functionally with Clinical Development, Medical Affairs, Regulatory Affairs, Commercial, and Corporate Communications, the Director will drive publication planning, scientific content development, medical education initiatives, and congress strategy while ensuring all communications are scientifically rigorous, compliant, and aligned with corporate objectives. This role will play a key part in establishing Satsuma as a scientific leader in migraine treatment and intranasal drug delivery technologies. The successful candidate participates with senior management to establish strategic plans and objectives for the scientific communications function, effectively cascading functional strategy and contributing to development of organizational policies, with a master-level understanding of the function and how it fits within the company and competitive environment.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Director